Navigation Links
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Date:6/1/2009

"As the leading cause of cancer deaths worldwide, lung cancer is a complex disease that requires new therapeutic options for patients," said Laura Brege, executive vice president and chief operating officer at Onyx Pharmaceuticals. "We are committed to studying Nexavar to understand how it may play a role in the treatment paradigm of this difficult-to-treat disease."

About Non-Small Cell Lung Cancer (NSCLC)

NSCLC accounts for 85-90 percent of diagnosed lung cancers(1) and is a disease in which malignant (cancer) cells form in the tissues of the lung. It is characterized by several types of lung cancers, each of which grow and spread in different ways, including: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.(1)

Every year 1.4 million people worldwide will be diagnosed with lung cancer and 1.2 million will die from the disease.(2) Nearly 60 percent of Americans diagnosed with lung cancer die within one year of their diagnosis and 75 percent die within 2 years. These survival rates have not improved in the past 10 years.(3)

Nexavar's Differentiated Mechanism

Nexavar, an oral anti-cancer therapy, is currently approved in more than 70 countries for liver cancer and in more than 80 countries for the treatment of patients with advanced kidney cancer. Nexavar targets both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to target members of two classes of kinases known to be involved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators as a single agent or combination treatment in a wide range of cancers, including, brea
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Bayer Temporarily Suspends Global Trasylol(R) Marketing
8. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
9. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
10. Bayer Awards Making Science Make Sense Grant to Girl Scouts
11. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... AZ (PRWEB) June 02, 2015 The 3TVPhoenix ... viewers to watch the station’s 6:00 a.m. Good Morning Arizona ... entered on the station’s Facebook page. , Lisa ... code-entering participants. She plans to apply the monthly $1,000 ... Allen, a stay-at-home mom, expressed her surprise and gratitude ...
(Date:6/2/2015)... N.Y. (PRWEB) June 02, 2015 The ... to computer generated imagery overlaid on the real world. ... but Vein Visualization, which displays a map of the ... a steady growth in adoption. , AccuVein, the leader ... year over year growth rate and such widespread adoption ...
(Date:6/2/2015)... 02, 2015 The nation’s first ... ( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is now underway in California ... documents, opening statements were presented on May 28th, ... on the Profemur hip replacement made the device ... snap just three years after it had been ...
(Date:6/2/2015)... June 02, 2015 TMG Health, the ... health plans in the Medicare Advantage, Medicare Part D, ... sponsor and exhibitor at AHIP’s Institute 2015, the annual ... Plans. The conference will be held June 3-5 in ... will offer opportunities for attendees to schedule private discussions ...
(Date:6/2/2015)... Did you wish Ryder Weise a happy sixth birthday ... isn’t asking for presents, but instead a donation to the ... HHT DC Walk. , Ryder was diagnosed with HHT in ... leading to sudden and extreme bleeding throughout the body. Though ... years old in the form of daily nosebleeds, fatigue and ...
Breaking Medicine News(10 mins):Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2
... kidney disease arent referred to kidney specialists in time ... a variety of reasons, according to researchers at Wake ... An analysis of 18 separate studies found that overall, ... and suffering from multiple health problems are patient characteristics ...
... Minn. -- The incidence of type 2 diabetes is ... sedentary lifestyles and obesity abound. In addition to weight ... for developing type 2 diabetes. The incidence of diabetes ... highest prevalence. An estimated 32 million Asian Indians have ...
... NEW YORK, Feb. 29 Philips Electronics (PHG) on ... its kind, during,a media tour of the new Mercy ... doors on March 16., , (See video from ... The canvas, displayed in the Women,s and Children,s waiting ...
... PRINCETON, N.J., Feb. 29 Richard P. Miller,of Marlton, ... was,installed as chairman of the board of the New ... official,installation, as well as the appointment of new board ... Hyatt Regency Princeton., "As we look to the ...
... LLC, a,Minneapolis-based privately-held holdings company, has launched ... experienced,interim and contract resources to Minneapolis-St. Paul ... breakthrough in one of the key problems ... Norbom, President and,Founder of Vallon LifeScience. "...how ...
... 2008 Official Shoes are Now On Sale, WHITE PLAINS, ... with Famous Footwear(TM) and Dr. Scholl,s(R) to,introduce the 2008 Official ... year, Famous Footwear and Dr. Scholl,s are,raising funds for March ... specially designed one men,s and two women,s athletic shoes to,be ...
Cached Medicine News:Health News:Study identifies reasons patients referred late to nephrologists 2Health News:Mayo researchers look for explanation behind high incidence of diabetes among Asian Indians 2Health News:Mayo researchers look for explanation behind high incidence of diabetes among Asian Indians 3Health News:VIDEO from Medialink and Philips: Philips Electronics Unveils First 'Imagination Light Canvas' at the New Mercy Medical Center in Rogers AR 2Health News:New Jersey Hospital Association Names New Chairman, Appoints Board Officers and New Members 2Health News:Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry 2Health News:Famous Footwear, Dr. Scholl's Step Up to Support March for Babies 2008 2
(Date:6/2/2015)... Md. , June 2, 2015 The ... of its National Practice Guideline for the Use of ... ( Practice Guideline ).  The Practice Guideline ... related to opioid use. It addresses knowledge gaps about ... recovery, while guiding evidence-based coverage standards by payers. ...
(Date:6/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/ctd7zx/europe ) has announced the ... And Forecasts (2014 - 2019)" report to their offering. ... Germany . This is followed by UK ... Poland are the fastest growing segments. ... segmented on the basis of Product (Film Screen, Digital, 3D, ...
(Date:6/2/2015)... 2, 2015 The Canadian Society for Vascular Surgery ... treatments or procedures that are commonly ordered but ... of Choosing Wisely Canada.  The list identifies five ... between patients and physicians about what care is ... Vascular Surgery,s list identified the following five (5) ...
Breaking Medicine Technology:American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 2American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 3Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4
... Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) today announced that the following presentations,will be made ... the 44th American Society of Clinical Oncology (ASCO) Annual Meeting,May 30 through June 3, ... Poster # Title ... (Abstract#) Sat., 8:00 AM ...
... May 26 Arpida Ltd (SWX:,ARPN) today announced ... Phase II,"intravenous-to-oral" switch trial with oral iclaprim in ... on track for,completion in 2008., The key ... clinical efficacy of an,oral capsule formulation of iclaprim ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 2Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 3
Foam Cervical Collar is medium-firm density. Breathable. Deeply anatomically contoured. Natural color, 100% cotton stockinette-covered for comfort. 2" hook and loop closures are another mark of quali...
Ezy Wrap® Economy Contour Cervical Collar Medium-density urethane foam. Synthetic white stockinette cover. Reverses for flexion or extension. (Contact closure. Hand wash. Air dry. 10/pack.)...
Exo-Deluxe Overhead Traction for hospital or home care. Twice the clearance of other units between the patient and supporting wall. 2" nylon pulleys with polypropylene cord, head halter, spreader bar...
... Aspen® Cervical Collars improves patient compliance, ... costs. Adjusts to user's anatomy, wicks ... head weight to shoulders and upper ... Front and back airflow openings. Adjustable ...
Medicine Products: